Does PALIVIZUMAB Cause Bronchial hyperreactivity? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Bronchial hyperreactivity have been filed in association with PALIVIZUMAB (Synagis). This represents 0.2% of all adverse event reports for PALIVIZUMAB.
18
Reports of Bronchial hyperreactivity with PALIVIZUMAB
0.2%
of all PALIVIZUMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Bronchial hyperreactivity From PALIVIZUMAB?
Of the 18 reports, 13 (72.2%) required hospitalization.
Is Bronchial hyperreactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
What Other Drugs Cause Bronchial hyperreactivity?
ALBUTEROL (173)
MONTELUKAST (110)
TIOTROPIUM (108)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (89)
CICLESONIDE (81)
PREDNISONE (79)
BUDESONIDE\FORMOTEROL (76)
MEPOLIZUMAB (72)
FLUTICASONE\SALMETEROL (59)
ONDANSETRON (59)
Which PALIVIZUMAB Alternatives Have Lower Bronchial hyperreactivity Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE